As India nears the rollout of ZyCoV-D, the world’s first DNA-based, needle-free Covid vaccine for individuals aged 12 years and above, one Bengaluru trial site gave the low-down on how the much talked about jab works.
Over the last two years, there has been an unprecedented frenzy to develop new vaccines due to the COVID-19 pandemic, but DNA vaccines have rather stood in the shadow of their mRNA cousins.
The ZyCoV-D vaccine heralds a wave of DNA vaccines for various diseases that are undergoing clinical trials around the world.
GOLDEN, Colo. — September 14, 2021 - PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Scancell, has selected its devices to administer its two SARS-CoV-2 DNA vaccine candidates, SCOV1 and SCOV2. The vaccines will be exclusively administered using the PharmaJet Tropis® and PharmaJet Stratis® Needle-free Injection Systems.
We take a look at some of the COVID-19 vaccine candidates moving through clinical trials.
On Friday, the Indian government authorized a needle-free Covid-19 vaccine developed by an indigenous pharmaceutical company.